Kevin Boyle Sr - Chief Executive Officer, Ziopharm Oncology Inc
As of November 17, 2021
Kevin Boyle Sr Net Worth
- Owns at least 885,000 units of Ziopharm Oncology Inc stock
Kevin Boyle Sr Trading
- Largest purchase of shares was 10,000 units , worth over $14K on November 17, 2021
- In total has made about 2 transactions over 3 months
- Usually trades in August and November, with the busiest year in 2021
Kevin Boyle Sr
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Kevin Boyle Sr Mailing Address
- Mailing address is C/o Ziopharm Oncology, Inc. One First Avenue, Parris Bldg 34 Boston MA 02129 MA
Ziopharm Oncology Inc Insider Trading
- The most recent transaction was 20,132 units sold on December 27, 2021 by Eleanor de Groot worth over $25.57K
- In the last 14 years, insiders at Ziopharm Oncology Inc sold an estimated value of $13.56M and bought an estimated value of $76.75M
- The most active traders are Randal Kirk, Director, Intrexon Corp, and Anthony James Cannon, Director
- Insider trading is most common in January, with the busiest year in 2017
ZIOPHARM ONCOLOGY INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |